17.15 USD
↘ 0.61 (3.43%)AT CLOSE (11:59 AM EDT)
Latigo Biotherapeutics, Inc. Common Stock
LTGONASDAQ • USD
17.20
↗ 0.05 (0.26%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
17.20
↗ 0.05 (0.26%)
Market: CLOSED
Latigo Biotherapeutics, Inc. Common Stock (LTGO) is currently trading at $17.15. Technical indicators currently signal "Strong Sell". Notable factors include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Sep 25, 2026.
Open?$17.81
High?$18.26
Low?$17.00
Prev. Close?$17.76
Volume?275.7K
Avg. Volume?N/A
VWAP?$17.42
Bid / Ask
Bid?$17.00 × 100
Ask?$28.40 × 200
Spread?$11.40
Midpoint?$22.70
Valuation & Ratios
Market Cap?1.1B
Shares Out?N/A
Float?62.2M
Float %?98.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Employees
N/A
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-08-07
Address
1300 RANCHO CONEJO BLVD., SUITE 305
THOUSAND OAKS, CA
Phone: 805-716-2927
THOUSAND OAKS, CA
Phone: 805-716-2927
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.72%Low
Short Interest?450.0K
Days to Cover?2.1
Free Float62.2M
Avg Daily Volume213.4K
Settlement Date2026-09-15